首页|环泊酚与丙泊酚对胸腔镜下肺癌根治术患者术后疲劳影响的比较研究

环泊酚与丙泊酚对胸腔镜下肺癌根治术患者术后疲劳影响的比较研究

扫码查看
目的 比较环泊酚与丙泊酚对胸腔镜下肺癌根治术患者术后疲劳(postoperative fatigue,POF)的影响。方法 招募郑州市金水区总医院2023年8月至2024年2月择期行胸腔镜下肺癌根治术的患者120例,随机分成环泊酚组(C组)和丙泊酚组(P组),每组60例。麻醉诱导:C组麻醉诱导静脉注射环泊酚0。4 mg/kg,P组麻醉诱导静脉注射丙泊酚2。0 mg/kg,随后两组均静脉注射罗库溴铵0。6~0。8 mg/kg,舒芬太尼0。2~0。4 μg/kg。麻醉维持:C组静脉输注环泊酚0。8~2。4mg/(kg·h);P组静脉输注丙泊酚4。0~12。0 mg/(kg·h)。两组均静脉输注罗库溴铵0。1~0。3 μg/(kg·min),静脉输注瑞芬太尼0。3~0。6 mg/(kg·h)。主要观察指标:术前1 d、术后1、3、7 d的疲劳程度评估量表(FSS)评分。次要观察指标:在手术后48 h内评估疼痛视觉模拟评分(VAS)、Ramsay镇静评分以及不良事件发生率。同时,采集术前1 d、术后1 d和术后3 d的外周静脉血样本,检测血清中肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)、白细胞介素-6(interleukin-6,IL-6)和白细胞介素-8(interleukin-8,IL-8)的浓度。结果 与术前1 d比较,术后1、3、7d时两组FSS评分均升高,差异有统计学意义(P<0。05);与P组比较,C组术后1、3、7 d时FSS评分均降低,差异有统计学意义(P<0。05)。术后7 d内,P组共有23例(38。3%)患者发生POF,C组共有9例(15。0%)患者发生POF,C组POF发生率显著低于P组,差异有统计学意义(P<0。05)。术后48 h内,两组患者VAS评分和Ramsay镇静评分差异均无统计学意义(P>0。05)。术后2 d内,两组之间镇痛补救率和PCIA泵总按压次数以及有效按压次数均未显示差异有统计学意义(P>0。05)。相较于P组,C组在术后48 h内呕吐发生率显著降低(P<0。05)。在术后1d和3d,两组之间血清中TNF-α、IL-6和IL-8浓度差异均无统计学意义(P>0。05)。结论 相较于丙泊酚,环泊酚可以显著降低胸腔镜下肺癌根治术患者术后POF及恶心呕吐发生率,而对炎性反应无明显影响。
Comparative study of effects of propofol and propofol on postoperative fatigue in patients undergoing thoracoscopic radical resection of lung cancer
Objective To compare the effects of ciprofol and propofol on postoperative fatigue(POF)in patients with thoracoscopic radical mastectomy for lung cancer.Methods One hundred and twenty patients undergoing thoracoscopic radical mastectomy for lung cancer were enrolled and the subjects were allocated into ciprofol group(group C)and propofol group(group P),with 60 subjects in each group,according to a random number table method.Anesthesia in-duction:group C was anesthetized with intravenous injection of 0.4 mg/kg of propofol,group P was anesthetized with intravenous injection of 2.0 mg/kg of propofol,followed by intravenous injection of 0.6-0.8 mg/kg of rocuronium bro-mide and 0.2-0.4 mg/kg of sufentanil in both groups µg/kg.Anesthesia maintenance:group C received intravenous infusion of 0.8~2.4 mg/(kg·h)of propofol;group P received intravenous infusion of propofol 4.0-12.0 mg/(kg·h).Both groups received intravenous infusion of rocuronium 0.1-0.3 μg/(kg·min)and intravenous infusion of remifentanil 0.3-0.6 mg/(kg·h).The main outcomes were the fatigue scale(FSS)scores at 1 day before surgery and 1,3,7 days after surgery were evaluated.The secondary outcomes were as follows:the visual analogue scale(VAS),Ramsay sedation score and the incidence of adverse events were evaluated within 48 hours after surgery.At the same time,peripheral venous blood samples were collected at 1 day before operation,1 day after operation and 3 days af-ter operation to detect the concentrations of tumor necrosis factor-α(TNF-α),interleukin-6(IL-6)and interleu-kin-8(IL-8)in serum.Results Compared with 1 d before operation,the FSS scores of the two groups increased at 1,3 and 7 d after surgery(P<0.05).Compared with the group P,the FSS scores of the group C decreased significantly at 1,3 and 7 days after surgery(P<0.05).Within 7 days after surgery,23 patients(38.3%)in the group P devel-oped POF,9 patients(15.0%)in the group C developed POF.The incidence of POF in the group C was significantly lower than that in the group P(P<0.05).The VAS scores and Ramsay sedation scores of the two groups of patients were similar at different time points after surgery within 48 h(P>0.05).Within 2 days after operation,there was no significant difference in the analgesic remedy rate,total pressing times of PCIA pump and effective pressing times be-tween the two groups(P>0.05).Compared with group P,the incidence of vomiting in group C was significantly lower within 48 h after operation(P<0.05).Conclusion Compared with propofol,propofol can significantly reduce the in-cidence of postoperative POF and nausea and vomiting in patients undergoing thoracoscopic radical resection of lung cancer,but has no significant effect on inflammatory response.

CiprofolPostoperative fatigueThoracoscopic surgeryLung cancerInflammation

冯炎超、任学军

展开 >

郑州市金水区总医院麻醉科,郑州 450000

河南中医药大学第一附属医院麻醉科,郑州 450003

环泊酚 术后疲劳 胸腔镜手术 肺癌 炎性反应

河南省科技研发计划联合基金资助项目

232103810054

2024

医药论坛杂志
中华预防医学会,河南省医学情报研究所

医药论坛杂志

影响因子:0.47
ISSN:1672-3422
年,卷(期):2024.45(15)